Exicure (XCUR) Current Assets (2016 - 2026)
Exicure (XCUR) reported Current Assets of $3.5 million for Q1 2026, down 68.76% on a YoY basis from $11.3 million in Q1 2025, and down 23.62% quarter-over-quarter from $4.6 million in Q4 2025.
Exicure (XCUR) Current Assets (2016 - 2026) Analysis & Trends
Exicure has reported Current Assets for 11 years, with the latest figure at $3.5 million in Q1 2026.
- For the quarter ending Q1 2026, Current Assets fell 68.76% year-over-year to $3.5 million; the trailing twelve-month figure through Mar 2026 stood at $3.5 million (down 68.76% YoY), and the FY2025 full-year result was $4.6 million, down 66.18% from the prior year.
- Current Assets for Q1 2026 stood at $3.5 million, down from $4.6 million in the prior quarter.
- The five-year high for Current Assets was $29.2 million in Q1 2022, with the low at $1.5 million in Q1 2024.
- Historically, Current Assets has averaged $9.1 million across 5 years, with a median of $5.4 million in 2025.
- Annual changes were most pronounced in 2024 — Current Assets slumped 87.03% — and 2025, when it jumped 672.73%.
- Exicure's Current Assets stood at $10.1 million in 2022, then tumbled by 79.86% to $2.0 million in 2023, then surged by 575.54% to $13.7 million in 2024, then sank by 66.18% to $4.6 million in 2025, then decreased by 23.62% to $3.5 million in 2026.
- The last three Current Assets figures came in at $3.5 million (Q1 2026), $4.6 million (Q4 2025), and $5.4 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | 37.31 Mn |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | 521.86 Mn |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | 10.37 Mn |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | 1.25 Bn |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | 3.59 Mn |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | 7.63 Mn |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | 11.73 Bn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | 600.85 Mn |
| 10 | Exicure | 19.38 Mn | 16.77 Mn | - | 3.53 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.53 Mn |
| Dec 31, 2025 | 4.62 Mn |
| Sep 30, 2025 | 5.44 Mn |
| Jun 30, 2025 | 8.65 Mn |
| Mar 31, 2025 | 11.31 Mn |
| Dec 31, 2024 | 13.67 Mn |
| Sep 30, 2024 | 2.60 Mn |
| Jun 30, 2024 | 2.08 Mn |
| Mar 31, 2024 | 1.46 Mn |
| Dec 31, 2023 | 2.02 Mn |
| Sep 30, 2023 | 3.09 Mn |
| Jun 30, 2023 | 3.66 Mn |
| Mar 31, 2023 | 11.28 Mn |
| Dec 31, 2022 | 10.05 Mn |
| Sep 30, 2022 | 17.20 Mn |
| Jun 30, 2022 | 24.72 Mn |
| Mar 31, 2022 | 29.18 Mn |
| Dec 31, 2021 | 43.67 Mn |
| Sep 30, 2021 | 64.15 Mn |
| Jun 30, 2021 | 60.65 Mn |